Terms: = Thyroid cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997
20568 results:
1. Feasibility and safety of modified en-bloc resection in endoscopic thyroid surgery via bilateral areolar approach - long-term institutional analysis ten years after surgery.
Xie Q; Ma J; Du Y; Liu L; Zhu R; Liu D; Wang P; Yu X
Front Endocrinol (Lausanne); 2024; 15():1302510. PubMed ID: 38694946
[TBL] [Abstract] [Full Text] [Related]
2. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
4. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract] [Full Text] [Related]
5. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
6. 2022 Fukushima Medical University International Symposium on the Fukushima Health Management Survey Build Back Better, Together. "Science for Society: Advancing Fukushima's Well-Being".
Tsubokura M; Kamiya K
Fukushima J Med Sci; 2024; 70(2):103-106. PubMed ID: 38684412
[TBL] [Abstract] [Full Text] [Related]
7. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
8. Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
Yang L; Murthy S; Cortellini A; Lim EA; Gonzalez M; Pinato DJ; Abdel-Malek M; Mahmoud S; Martin NM
Front Endocrinol (Lausanne); 2024; 15():1369268. PubMed ID: 38681767
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Value of Immunostaining for thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
11. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
[TBL] [Abstract] [Full Text] [Related]
12. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
[TBL] [Abstract] [Full Text] [Related]
13. thyroid US-guided FNA techniques: A prospective,randomized controlled study.
Cohn S; Farhat R; El Khatib N; Asakly M; Khater A; Safia A; Karam M; Massoud S; Bishara T; Avraham Y; Sharabi-Nov A; Merchavy S
Am J Otolaryngol; 2024; 45(1):104091. PubMed ID: 38652678
[TBL] [Abstract] [Full Text] [Related]
14. Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.
Wang P; Dong Z; Zhao S; Su Y; Zhang J; Ma Y; Diao C; Qian J; Cheng R; Liu W
Front Endocrinol (Lausanne); 2024; 15():1349272. PubMed ID: 38638135
[TBL] [Abstract] [Full Text] [Related]
15. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
16. Multiple and hereditary renal tumors: a review for radiologists.
Corral de la Calle MÁ; Encinas de la Iglesia J; Fernández Pérez GC; Fraino A; Repollés Cobaleda M
Radiologia (Engl Ed); 2024; 66(2):132-154. PubMed ID: 38614530
[TBL] [Abstract] [Full Text] [Related]
17. Association between Consumption of Iodine-Rich Foods and thyroid cancer Prevalence: Findings from a Large Population-Based Study.
Kwon YJ; Lee HS; Kang SW; Lee JW
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613074
[TBL] [Abstract] [Full Text] [Related]
18. A meta-analysis of unilateral axillary approach for robotic surgery compared with open surgery for differentiated thyroid carcinoma.
Zhang X; Yu J; Zhu J; Wei H; Meng N; Hu M; Tang J
PLoS One; 2024; 19(4):e0298153. PubMed ID: 38603661
[TBL] [Abstract] [Full Text] [Related]
19. A machine learning approach for predicting radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma undergoing tomotherapy.
Quan KR; Lin WR; Hong JB; Lin YH; Chen KQ; Chen JH; Cheng PJ
Sci Rep; 2024 Apr; 14(1):8436. PubMed ID: 38600141
[TBL] [Abstract] [Full Text] [Related]
20. Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study.
Christensen SK; Winther ML; Laursen IJ; Madsen FS; Brink C; Brix TH; Ellebaek E; Svane IM; Hansen FS; Haslund C; Laursen OK; Schmidt H; Larsen ID; Bastholt L; Ruhlmann CH
Support Care Cancer; 2024 Apr; 32(5):281. PubMed ID: 38598052
[TBL] [Abstract] [Full Text] [Related]
[Next]
